Quest Diagnostics (DGX) Other financing activities (2016 - 2026)
Quest Diagnostics' Other financing activities history spans 18 years, with the latest figure at -$84.0 million for Q1 2026.
- On a quarterly basis, Other financing activities fell 37.7% to -$84.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.0 million, a 33.33% increase, with the full-year FY2025 number at $39.0 million, up 85.71% from a year prior.
- Other financing activities hit -$84.0 million in Q1 2026 for Quest Diagnostics, down from $100.0 million in the prior quarter.
- Over the last five years, Other financing activities for DGX hit a ceiling of $100.0 million in Q4 2025 and a floor of -$84.0 million in Q1 2026.
- Historically, Other financing activities has averaged -$2.9 million across 5 years, with a median of $3.0 million in 2024.
- The widest YoY moves for Other financing activities: up 244.44% in 2023, down 866.67% in 2023.
- Tracing DGX's Other financing activities over 5 years: stood at -$20.0 million in 2022, then skyrocketed by 190.0% to $18.0 million in 2023, then surged by 216.67% to $57.0 million in 2024, then surged by 75.44% to $100.0 million in 2025, then plummeted by 184.0% to -$84.0 million in 2026.
- Business Quant data shows Other financing activities for DGX at -$84.0 million in Q1 2026, $100.0 million in Q4 2025, and -$11.0 million in Q3 2025.